MedPath

Clinical study of the effectiveness of Saireito on the postoperative edema after blepharoptosis surgery

Phase 2
Conditions
blepharoptosis
Registration Number
JPRN-UMIN000016258
Lead Sponsor
Kansai Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

*Have herbal remedy orally within 2weeks before surgery *Have any of the following systemic diseases: 1.Requiring continued use of oral corticosteroid therapy (>5 mg/day prednisolone equivalent) or immune-suppressing drug 2.malignant tumor 3.hepatuc failure or renal failure *6.Other patients judged by the investigator to be inappropriate as a subject of this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath